Ketamine Treatment Effects on Synaptic Plasticity in Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
Major Depressive Disorder
Interventions
DRUG

Ketamine

"Subjects will undergo 4 sequential intravenous infusions of ketamine administered over a two week period.~Ketamine is administered at a dose of 0.5mg/kg intravenously as a slow continuous infusion over approximately 40 minutes, with 4 sequential infusions over an approximately two week period (two infusions per week for two weeks)."

Trial Locations (1)

10032

New York State Psychiatric Institute/Columbia University, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT04091971 - Ketamine Treatment Effects on Synaptic Plasticity in Depression | Biotech Hunter | Biotech Hunter